Cargando…
Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review
Wilms tumor is the most common pediatric abdominal solid tumor, and its treatment has been a focus of research. For now, the 5-year survival rate of children with Wilms tumor is about 90%. It is difficult to make further progress simply by the improvement of the existing treatments (multi-modal ther...
Autores principales: | Hong, Bo, Dong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799117/ https://www.ncbi.nlm.nih.gov/pubmed/35116480 http://dx.doi.org/10.21037/tcr-20-3302 |
Ejemplares similares
-
Recent advances in the management of Wilms' tumor
por: Lopes, Roberto I., et al.
Publicado: (2017) -
Adult Wilms’ tumor – diagnosis and current therapy
por: Huszno, Joanna, et al.
Publicado: (2013) -
Many faces of Wilms Tumor: Recent advances and future directions
por: Bhutani, Namita, et al.
Publicado: (2021) -
Systematic review of the immunological landscape of Wilms tumors
por: Palmisani, Francesca, et al.
Publicado: (2021) -
The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review
por: Rajan, Arun, et al.
Publicado: (2021)